Search research articles
Contact Us
Filters
Showing results (71-80 of 85) with videos related to
Page
of 9
Sort By:
Open Forum Infectious Diseases
|
March 26, 2025
Impact of Antibiotic Duration on Gut Microbiome Composition and Antimicrobial Resistance: A Substudy of the BALANCE Randomized Controlled Trial
Eric Armstrong, Maria Kulikova, Noelle Yee, et al.
British Journal of Cancer
|
May 7, 2024
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
Marc Oliva, Alya Heirali, Geoffrey Watson, et al.
British Journal of Cancer
|
March 22, 2021
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, et al.
Ebiomedicine
|
March 6, 2025
Cellular blueprint of healthy and diseased human epiglottis and subglottis-a study of the Canadian Airways Research (CARE) group
Peter Y F Zeng, R Jun Lin, Kevin Fung, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)
Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.
Ebiomedicine
|
March 6, 2025
Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian Airways Research (CARE) group
R Jun Lin, Peter Y F Zeng, Kevin Fung, et al.
BMJ Open
|
December 8, 2025
Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE
Nick Daneman, Jennie Johnstone, Todd C Lee, et al.
Trials
|
February 18, 2018
7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial
Nick Daneman, Asgar H Rishu, Ruxandra Pinto, et al.
JAMA Network Open
|
February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial
Emily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial
Abdulazeez Salawu, Ben X Wang, Ming Han, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 85) with videos related to
Sort By:
Page
of 9
Open Forum Infectious Diseases
|
March 26, 2025
Impact of Antibiotic Duration on Gut Microbiome Composition and Antimicrobial Resistance: A Substudy of the BALANCE Randomized Controlled Trial
Eric Armstrong, Maria Kulikova, Noelle Yee, et al.
British Journal of Cancer
|
May 7, 2024
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study
Marc Oliva, Alya Heirali, Geoffrey Watson, et al.
British Journal of Cancer
|
March 22, 2021
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
Marc Oliva, Pierre H H Schneeberger, Victor Rey, et al.
Ebiomedicine
|
March 6, 2025
Cellular blueprint of healthy and diseased human epiglottis and subglottis-a study of the Canadian Airways Research (CARE) group
Peter Y F Zeng, R Jun Lin, Kevin Fung, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 21, 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)
Sofia Genta, Katherine Lajkosz, Noelle R Yee, et al.
Ebiomedicine
|
March 6, 2025
Cohort-level clinical trajectory and molecular landscape of idiopathic subglottic stenosis for precision laryngology-a study of the Canadian Airways Research (CARE) group
R Jun Lin, Peter Y F Zeng, Kevin Fung, et al.
BMJ Open
|
December 8, 2025
Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE
Nick Daneman, Jennie Johnstone, Todd C Lee, et al.
Trials
|
February 18, 2018
7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial
Nick Daneman, Asgar H Rishu, Ruxandra Pinto, et al.
JAMA Network Open
|
February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial
Emily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2023
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial
Abdulazeez Salawu, Ben X Wang, Ming Han, et al.
Page
of 9